E-LIB Suche - Ergebnisse für: Liesner, Ri

1

Validation of a perioperative population factor VIII pharma..:

Preijers, Tim ; Liesner, Ri ; Hazendonk, Hendrika C. A. M....
British Journal of Clinical Pharmacology. 87 (2021) 11 - p. 4408-4420 , 2021

Link: https://doi.org/10.1111/..

2

Immune tolerance induction in severe haemophilia A: A UKHCD..:

Hart, Daniel P. ; Alamelu, Jayanthi ; Bhatnagar, Neha...
Haemophilia. 27 (2021) 6 - p. 932-937 , 2021

Link: https://doi.org/10.1111/..

3

Diagnosis, therapeutic advances, and key recommendations fo..:

Peyvandi, Flora ; Auerswald, Guenter ; Austin, Steven K....
Blood Reviews. 50 (2021) - p. 100833 , 2021

Link: https://doi.org/10.1016/..

4

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients wi..:

Liesner, Ri J. ; Abraham, Aby ; Altisent, Carmen...
Thrombosis and Haemostasis. 121 (2021) 11 - p. 1400-1408 , 2021

Link: https://doi.org/10.1055/..

5

Feasibility, safety and acceptability of select outcome mea..:

Thorpe, Nicola ; Harniess, Phillip ; Main, Eleanor...
Pilot and Feasibility Studies. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

6

Plasma‐derived factor X concentrate compassionate use for h..:

Huang, James N. ; Liesner, Ri ; Austin, Steven K...
Research and Practice in Thrombosis and Haemostasis. 5 (2021) 5 - p. e12550 , 2021

Link: https://doi.org/10.1002/..

7

Assessing thrombogenesis and treatment response in congenit..:

Alwan, Ferras ; Vendramin, Chiara ; Budde, Ulrich...
eJHaem. 2 (2021) 2 - p. 188-195 , 2021

Link: https://doi.org/10.1002/..

8

Validation of a perioperative population factor VIII pharma..:

Preijers, Tim ; Liesner, Ri ; Hazendonk, Hendrika C. A. M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596686/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Plain language summary for the manuscript: Safety and effic..:

Ri Liesner (68878) ; Andersson NG (11858443) ; Frisk T (11858444)...
https://figshare.com/articles/journal_contribution/Plain_language_summary_for_the_manuscript_Safety_and_efficacy_of_nonacog_alfa_for_the_treatment_of_haemophilia_B_in_children_younger_than_6_years_of_age_in_a_routine_clinical_care_setting_the_EUREKIX_registry_study/17299349. , 2021

Link: https://doi.org/10.25454..

10

Assessing thrombogenesis and treatment response in congenit..:

Alwan, Ferras ; Vendramin, Chiara ; Budde, Ulrich...
https://discovery.ucl.ac.uk/id/eprint/10176864/1/Assessing%20thrombogenesis%20and%20treatment%20response%20in%20congenital%20thrombotic%20thrombocytopenic%20purpura.pdf. , 2021

Link: https://discovery.ucl.ac..

11

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients wi..:

Liesner, Ri J ; Abraham, Aby ; Altisent, Carmen...
info:eu-repo/semantics/altIdentifier/doi/10.1055/s-0040-1722623. , 2021

Link: https://hal.science/hal-..

12

Validation of a perioperative population factor VIII pharma..:

Preijers, Tim ; Liesner, Ri ; Hazendonk, Hendrika C. A. M...
https://research.rug.nl/en/publications/adb1d789-0edf-4c85-977e-d359268f40c5. , 2021

Link: https://hdl.handle.net/1..

13

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients wi..:

Liesner, Ri J ; Abraham, Aby ; Altisent, Carmen...
info:eu-repo/semantics/altIdentifier/doi/10.1055/s-0040-1722623. , 2021

Link: https://hal.science/hal-..

14

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients wi..:

Liesner, Ri J ; Abraham, Aby ; Altisent, Carmen...
info:eu-repo/semantics/altIdentifier/doi/10.1055/s-0040-1722623. , 2021

Link: https://hal.science/hal-..

15

Additional file 1 of Feasibility, safety and acceptability ..:

Nicola Thorpe (10760451) ; Phillip Harniess (10760454) ; Eleanor Main (10760457)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Feasibility_safety_and_acceptability_of_select_outcome_measures_in_a_physiotherapy_study_protocol_for_boys_with_haemophilia/14551587. , 2021

Link: https://doi.org/10.6084/..